Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)
0
Authors
Franck Morschhauser
22 more
Franck Morschhauser
•
Elicia Penuel
20 more
•
Jeff Sharman
Published
March 29, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Haematology
Topics
Physics
Cancer Oncology
Medicine
Internal Medicine
Pathology And Forensic Medicine
Show all topics
DOI
10.1016/s2352-3026(19)30026-2
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Haematology
Topics
Physics
Cancer Oncology
Medicine
Internal Medicine
Pathology And Forensic Medicine
Show all topics
DOI
10.1016/s2352-3026(19)30026-2
License
publisher-specific-oa
